Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 650 of 2529 entries
View as:

Everolimus in de Novo Heart Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT01017029 Org: User:
Start: 09/30/09 End: 12/31/13 Due: 12/31/14

INC424 for Patients With Primary Myelofibrosis, Post Polycythemia Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis.

Phase: N/A Priority: Normal
NCT ID: NCT01493414 Org: User:
Start: 08/16/11 End: 01/26/17 Due: 01/26/18

Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol

Phase: N/A Priority: Normal
NCT ID: NCT01156844 Org: User:
Start: 03/31/10 End: - Due: -

Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular Occlusion

Phase: N/A Priority: Normal
NCT ID: NCT05657158 Org: User:
Start: 08/23/21 End: 01/04/22 Due: 01/04/23

Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02471144 Org: User:
Start: 09/29/15 End: 03/30/23 Due: 03/30/24

Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00403416 Org: User:
Start: 10/31/06 End: 05/31/08 Due: 05/31/09

Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib

Phase: N/A Priority: Normal
NCT ID: NCT01514448 Org: User:
Start: 05/21/12 End: 04/01/16 Due: 04/01/17

Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04632927 Org: User:
Start: 12/21/20 End: 10/22/24 Due: 10/22/25

Impact of Fingolimod Adherence on Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT05141669 Org: User:
Start: 05/18/20 End: 11/20/20 Due: 11/20/21

Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01613326 Org: User:
Start: 06/30/12 End: 01/31/13 Due: 01/31/14

A First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of QCC374

Phase: N/A Priority: Normal
NCT ID: NCT02245828 Org: User:
Start: 07/31/14 End: 12/31/15 Due: 12/31/16

Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study

Phase: N/A Priority: Normal
NCT ID: NCT04084314 Org: User:
Start: 09/30/19 End: 03/13/23 Due: 03/13/24

Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.

Phase: N/A Priority: Normal
NCT ID: NCT05110196 Org: User:
Start: 09/03/22 End: 06/30/25 Due: 06/30/26

Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs

Phase: N/A Priority: Normal
NCT ID: NCT03106779 Org: User:
Start: 10/26/17 End: 12/04/24 Due: 12/04/25

A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines

Phase: N/A Priority: Normal
NCT ID: NCT05030311 Org: User:
Start: 11/30/21 End: 01/19/24 Due: 01/19/25

VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma)

Phase: N/A Priority: Normal
NCT ID: NCT04702425 Org: User:
Start: 06/23/21 End: 07/23/24 Due: 07/23/25

An Open-label, Parallel-group Study to Determine the Pharmacokinetics of a Single Dose of AFQ056 in Subjects With Renal Impairment Compared to Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01442259 Org: User:
Start: 01/31/11 End: 08/31/11 Due: 08/31/12

Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label)

Phase: N/A Priority: Normal
NCT ID: NCT01433354 Org: User:
Start: 11/30/11 End: 09/30/14 Due: 09/30/15

A Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in China

Phase: N/A Priority: Normal
NCT ID: NCT06053801 Org: User:
Start: 02/16/24 End: 10/01/25 Due: 10/01/26

A Dose-ranging Study to Evaluate the Safety and Efficacy of UNR844 in Subjects With Presbyopia.

Phase: N/A Priority: Normal
NCT ID: NCT04806503 Org: User:
Start: 06/30/21 End: 10/14/22 Due: 10/14/23

Study of Efficacy and Safety of LCZ696 in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction

Phase: N/A Priority: Normal
NCT ID: NCT02468232 Org: User:
Start: 06/15/15 End: 02/18/21 Due: 02/18/22

Effect of AIN457 on Ozone-induced Airway Neutrophilia Compared to Placebo and Corticosteroid in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00920933 Org: User:
Start: 01/31/09 End: - Due: -

Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01865188 Org: User:
Start: 04/30/14 End: 04/30/15 Due: 04/30/16

Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT01359943 Org: User:
Start: 10/31/11 End: 12/31/13 Due: 12/31/14

A Study to Assess the Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00351507 Org: User:
Start: 05/31/05 End: 02/28/06 Due: 02/28/07